Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Women with AGA have higher lipid levels, increasing heart disease risk.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride helps reduce heart enlargement in heart failure patients.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Osteoporotic postmenopausal Sudanese women have a high risk of cardiovascular disease.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Low-level laser therapy helps hair growth and reduces hair loss with few side effects.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Placental stem cell exosome therapy improves hair growth and reduces hair loss.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

Primary cilia affect the size and oil production of eye glands but not the oil's makeup.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.